Global pulmonary function testing market growth is driven by rising prevalence of chronic respiratory diseases, increasing geriatric population, and growing adoption of diagnostic monitoring ...

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

Are you feeling out of breath while talking or climbing stairs These silent symptoms may be the first signs of COPD that one ...

Strip away the business cases and market opportunities, and here's what matters: 454 million people are suffering [1]. Most ...

Research on adults 60-70 years old showed that after 16 weeks, participants who swam regularly showed significant ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.